Literature DB >> 27062395

Successful sperm extraction and live birth after radiation, androgen deprivation and surgical castration for treatment of metastatic prostate cancer.

G J A Wood1, R P Hayden2, C Tanrikut2.   

Abstract

Fertility preservation has become an important aspect of cancer treatment given the gonadotoxic effects of oncologic therapies. It is now considered standard of care to offer sperm banking to men undergoing treatment for primaries that affect young individuals. Less is known regarding fertility preservation of patients afflicted with prostate cancer. This cohort has progressively expanded and grown younger in the post-PSA era. Prostatectomy, radiation, chemotherapy and androgen blockade all pose unique challenges to the infertility specialist. Optimum management becomes even more uncertain for those men with metastatic prostate cancer. Most of these individuals will have received multiple forms of therapy, each carrying a distinct insult to the patient's reproductive potential. We describe a case of successful ex vivo sperm extraction and live birth in a patient previously treated with radiation and chronic androgen deprivation for metastatic prostate cancer. The presented case demonstrates that conception after radiation therapy and chronic androgen deprivation is feasible. We propose that fertility counselling and sperm cryopreservation should be considered for all prostate cancer patients. Additionally, for those individuals undergoing external beam radiotherapy, testicular shielding should be routinely offered in the event further family building is desired.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  Fertility preservation; IVF-ICSI; metastatic prostate cancer; radiotherapy; sperm extraction

Mesh:

Year:  2016        PMID: 27062395     DOI: 10.1111/and.12578

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  1 in total

1.  Testicular sperm extraction in a patient with ejaculatory dysfunction after combined androgen blockade therapy for prostate cancer.

Authors:  Toshiyasu Amano; Chihiro Suzuki; Yuji Shimojima; Tetsuya Imao; Carolyn Earle
Journal:  IJU Case Rep       Date:  2020-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.